glucagon has been researched along with Acquired Metabolic Diseases, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blankenstein, O; Grimberg, A; Hardy, OT; Mohnike, K; Pfuetzner, A; Pötzsch, S; Schober, E; Steiner, S; van Waarde, WM | 1 |
| Asplin, CM; Koerker, DJ; Palmer, JP; Raghu, PK | 1 |
1 trial(s) available for glucagon and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
Topics: Blood Glucose; Brain Diseases, Metabolic; Congenital Hyperinsulinism; Female; Gastrointestinal Agents; Glucagon; Glycogen; Humans; Hypoglycemia; Infant, Newborn; Male; Octreotide; Pancreatectomy; Retrospective Studies | 2008 |
1 other study(ies) available for glucagon and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
Glucose counterregulation during recovery from neuroglucopenia: which mechanism is important?
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Brain Diseases, Metabolic; Deoxyglucose; Epinephrine; Glucagon; Glycerol; Hydroxybutyrates; Hypoglycemia; Insulin; Male; Papio; Propranolol; Receptors, Adrenergic, beta; Somatostatin | 1985 |